Welcome to My Blog

Here is a masonry blog layout with no sidebar

U.S. FDA safety guidelines likely to push COVID-19 vaccine authorization past election

The White House could still force authorization of a vaccine without that additional safety data. Doing so would put it in open disagreement with the FDA and its career scientists, and add to the perception that politics was playing a role in pushing out a vaccine.

If the agency follows its own guidelines, it is unlikely to authorize a vaccine before sometime in late November. It wants two months of data from half of a trial’s volunteers.

Airlines warn of more bankruptcies as wage support ends

Airlines consumed $51 billion in cash in the second quarter as the pandemic brought global travel to a near-standstill, the industry body said.
Whereas the withdrawal of subsidies makes sense for sectors in recovery, IATA warned of further airline bankruptcies in the northern hemisphere winter as the collapse in revenue continues to dwarf cost savings. The average carrier now has cash for 8.5 months of operations, Brian Pearce, chief economist at the International Air Transport Association (IATA), told reporters

COVID-19: 72,049 new cases take India’s virus tally to 67,57,131

The COVID-19 case fatality rate has further declined to 1.55 per cent.

There are 9,07,883 active cases of coronavirus infection in the country which comprises 13.44 per cent of the total caseload, the data stated

According to the ICMR, a cumulative total of 8,22,71,654 samples have been tested up to October 6 with 11,99,857 samples being tested on Tuesday.

One in 10 may have caught COVID, as world heads into ‘difficult period’: WHO

“Our current best estimates tell us about 10% of the global population may have been infected by this virus. It varies depending on country, it varies from urban to rural, it varies depending on groups. But what it does mean is that the vast majority of the world remains at risk,” Ryan said. “We are now heading into a difficult period. The disease continues to spread.”

Plastic pandemic: COVID-19 trashed the recycling dream

Plastic, most of which does not decompose, is a significant driver of climate change.

The manufacture of four plastic bottles alone releases the equivalent greenhouse gas emissions of driving one mile in a car, according to the World Economic Forum, based on a study by the drinks industry. The United States burns six times more plastic than it recycles, according to research in April 2019 by Jan Dell, a chemical engineer and former vice chair of the U.S. Federal climate committee.

New Reality: Securing “Intangible Assets”

Advancements in cyber-attacks and corporate espionage, along with increasing uncertainty in the business environment have pushed many organisations towards introducing stricter processes to protect confidential and proprietary intangible assets from threats such as intellectual property trademark and copyright infringements, data piracy and appropriation of trade secrets.
Many organizations’ approach their reputation challenges in a reactive way after an adverse event occurs. However, it’s important to understand that risk management depends on proactive reputation management. Negative publicity stemming from mismanagement or inadequate preparation can cause significant reputational damage.

SCOR to strengthen regional focus,carves out “APAC Emerging Market’ to be headed by India’s Mukul K

“This has led us to create a new position of P&C Regional Head – of EMEA and the Americas respectively – on top of our existing APAC organization, and to re-organize the reinsurance teams into four different regions with more homogenous client needs, i.e. Europe, North America, APAC Mature markets, and Fast-Growth markets.” said  SCOR Global P&C CEO Jean-Paul Conoscente ,

APAC Emerging Markets,that excludes SCOR’s operations in  Japan, South Korea & ANZ, will be led by Mukul Kishore, who continues as the CEO of SCOR’s India branch operations

COVID-19 cases in India breach 65-lakh mark

The total coronavirus cases mounted to 65,49,373 with 75,829 people testing positive for the infection in a day, while the death toll climbed to 1,01,782 with the virus claiming 940 lives in a span of 24 hours, the data updated at 8 am showed.

The total recoveries have surged to 55,09,966, while there are 9,37,625, active cases of coronavirus infection in the country which comprises 14.32 per cent of the total caseload, the data stated.
The recovery rate stands at 84.13 per cent.

The COVID-19 case fatality rate has further dropped to 1.55 per cent.

CEOs indicate business sentiment revival; steady recovery of Indian economy on anvil: CII

“While in most cases, the performance – revenue or capacity utilisation – is estimated to be lower than the comparative figures in 2019-20, a large percentage of the CEOs polled have shown confidence in the days ahead indicating that the worst may be behind,” CII said.
,The finance ministry on Sunday said the festive months were expected to further boost economic growth after high frequency indicators showed improvement. It, however, cautioned that the spread of Covid-19 and an increase in precautionary personal savings posed risks to the prospects of economic expansion.

Govt weighs legal options after losing Vodafone tax arbitration case

Finance Ministry sources said the government will decide on challenging the award before a court in Singapore – which was the seat of the arbitration, after taking legal opinion.While the cost implication in the case is limited to having to pay Rs 85 crore to Vodafone in legal cost, what is weighing on the government mind is a separate arbitration involving UK’s Cairn Energy plc.

India seeks up to 500 million coronavirus vaccine doses by July

“There is a high-level expert body going into all aspects of vaccines,” Vardhan wrote on Twitter. “Our rough estimate and the target would be to receive and utilise 400 to 500 million doses covering (200 million-250 million) people by July 2021.”

Serum Institute of India and private companies have been teaming up with organizations from the Bill & Melinda Gates Foundation to U.S. drug developer Novavax Inc in a scramble to secure vaccines for the country of 1.3 billion people.